Citation

Napoli N, Schwartz AV, Palermo L, Jin JJ, Wustrack R, Cauley JA, Ensrud KE, Kelly M, Black DM. J. Clin. Endocrinol. Metab. 2013; 98(2): 659-667.

Affiliation

Università Campus Bio-Medico di Roma (N.N.), 83-00155 Rome, Italy; Washington University (N.N., M.K.), St Louis, Missouri 63110; University of California, San Francisco (J.J.J., A.V.S., L.P., R.W., D.M.B.), San Francisco, California 94143; San Francisco Coordinating Center (A.V.S., L.P., D.M.B.), San Francisco, California 94107; University of Pittsburgh (J.A.C.), Pittsburgh, Pennsylvania 15260; Department of Medicine and Epidemiology (K.E.), University of Minnesota, Minneapolis, Minnesota 55455; and Minneapolis Veterans Affairs Health Care System (K.E.E.), Minneapolis, Minnesota 55417.

Copyright

(Copyright © 2013, Endocrine Society)

DOI

10.1210/jc.2012-1896

PMID

23345099

Abstract

Context:Patients on long-term bisphosphonate therapy may have an increased incidence of low-energy subtrochanteric and diaphyseal (SD) femoral fractures. However, the incidence and risk factors associated with these fractures have not been well defined.Objective:The objective of the study was to determine the incidence of and risk factors for low-energy SD fractures in the Study of Osteoporotic Fractures (SOF).Design:Low-energy SD fractures were identified from a review of radiographic reports obtained between 1986 and 2010 in women in the SOF. Among the SD fractures, pathological, periprosthetic, and traumatic fractures were excluded. We assessed risk factors for SD fractures as well as risk factors for femoral neck (FN) and intertrochanteric (IT) hip fractures using both age-adjusted and multivariate time-dependent proportional hazards models. During this follow-up, only a small minority had ever used bisphosphonates.Results:Forty-five women sustained low-energy subtrochanteric/diaphyseal femoral fractures over a total follow-up of 140 000 person-years. The incidence of SD fracture was 3.2 per 10 000 person-years compared with a total hip fracture incidence of 110 per 10 000 person-years. A total of about 12% of women reported bisphosphonate use at 1 or more visits. In multivariate analyses, age, total hip bone mineral density (BMD), bisphosphonate use, and history of diabetes emerged as independent risk factors for SD fractures. Risk factors for FN and IT fractures included age, BMD, and history of falls or prior fractures. Bisphosphonate use was protective against FN fractures, whereas there was an increased risk of SD fractures (hazard ratio 2.58, P = .049) with bisphosphonate use after adjustment for other risk factors for fracture.Conclusions:In SOF, low-energy SD fractures were rare occurrences, far outnumbered by FN and IT fractures. Typical risk factors were associated with FN and IT fractures, whereas only age, total hip BMD, and history of diabetes were independent risk factors for SD fractures. In addition, bisphosphonate use was a marginally significantly predictor although the SOF study has limited ability to assess this association.

Language: en